Company intelligence / Profile preview

TruElastin

Chatham, New Jersey, United Statestruelastin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

TruElastin is developing proprietary natural elastin-based biomaterials for use as dermal fillers and other medical devices. Their lead product is pre-clinical. The company aims to address unmet needs in aesthetics and potentially broader therapeutic areas by restoring or supplementing lost elastin in human tissues. No clinical results have been published yet.

Therapeutic areas: Dermatology
Modalities: BiologicDevice (dermal filler)Tissue-engineered product
Industry: Implantable Medical Devices

Drug pipeline

1 asset

TEL219

Pre-clinical

Indications: Facial wrinkles, Soft tissue augmentation

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on TruElastin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TruElastin.

Explore the full profile